PENSACOLA, Fla. - For some, fitness is a way of life. For others, it is an ugly, seven-letter word. For one naval aviator assigned to Naval Education and Training Command, it is a passion that has ...
Veru Inc. has pivoted to focus on preventing lean mass reduction in patients using GLP-1 agonists, leveraging its lead asset, enobosarm. A Phase 2b trial showed that a 3mg dose of Enobosarm reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback